查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1801264

2025 年至 2033 年乳房影像市场规模、份额、趋势及预测（按技术、最终用户和地区）

Breast Imaging Market Size, Share, Trends and Forecast by Technology, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球乳房影像市场规模达48.6亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到93亿美元，2025年至2033年的复合年增长率为7.10%。目前，北美占据乳房影像市场主导地位，2024年其乳房影像市场份额将超过37.5%。乳房影像市场的发展受到乳癌盛行率上升、影像技术进步以及政府提倡早期发现的倡议的推动。公众意识的提升、医疗基础设施的扩展以及人工智慧(AI)驱动的诊断技术进一步推动了市场成长。优惠的报销政策以及对精准、非侵入性筛检解决方案日益增长的需求也促进了行业扩张。

乳癌发生率的上升是乳房影像产业发展的主要驱动力，因此需要早期发现和先进的诊断解决方案。 2022年，全球约有230万名女性被诊断出罹患乳癌，导致约67万人死亡。然而，预测显示，到2050年，病例数将增加38%，死亡人数将增加68%。在美国，乳癌诊断率每年增长1%，50岁以下女性的诊断率每年增长1.4%。这一令人担忧的趋势促使政府加强宣传活动和倡议，提倡频繁筛检，推动了乳房X光检查、超音波检查和核磁共振成像技术的普及。三维(3D)乳房X光检查和人工智慧影像等技术进步提高了筛检准确性，减少了假阳性和不必要的活检。医疗保健基础设施的不断扩展，尤其是在新兴市场，改善了筛检中心的可近性，确保了更好的患者治疗效果，并推动了影像技术的持续创新。

美国乳房影像市场受高乳癌盛行率、先进的医疗基础设施以及政府大力推广早期筛检措施的驱动，市场份额高达88.90%。数位乳房断层合成 (DBT) 和人工智慧诊断等先进影像技术的广泛应用，提高了筛检的准确性和效率。优惠的报销政策以及美国癌症协会等组织所进行的宣传活动，进一步鼓励人们定期进行乳房X光检查。此外，主要产业参与者持续的研发投入也促进了技术进步，提高了成像精度。主要市场参与者的加入，加上医疗创新投资的不断增加，进一步增强了乳房影像市场的成长。保险覆盖范围的扩大和个性化诊断需求的不断增长，进一步推动了乳房影像解决方案在全美范围内的普及。

乳房影像市场趋势：

乳癌发生率上升

乳房影像市场的主要趋势之一是乳癌病例数量的增加，这是推动乳房影像产业成长的主要因素之一。早期发现可提高生存率，从而改善治疗效果，因此对先进影像的需求激增。根据世界卫生组织的数据，乳癌是女性最常见的癌症，因此必须及时准确检测乳癌。根据世界癌症研究基金会的数据，预计2030年将新增约210万例乳癌病例，这进一步证明了对有效筛检和影像解决方案的需求。乳癌病例的增加推动了先进影像技术的引入，同时也促使医疗系统和医疗服务提供者采用更好的安全诊断方案。早期发现对于改善治疗效果至关重要，而乳房影像服务的需求也在成长，以适应这些不断增长的需求变数和乳房影像市场。

成像技术的进步

乳房影像技术的持续进步显着提升了乳房疾病的检测和管理水平，预计将成为市场成长的关键驱动力。值得注意的是，数位乳房X光检查、3D断层合成、增强乳房X光检查以及人工智慧驱动的成像解决方案的进步，都有助于提高诊断的精准度和效率，从而推动其应用。此类创新使医疗保健提供者能够更早、更准确地诊断乳癌，从而改善患者的预后。近期一个很好的例子是通用电气医疗集团 (GE HealthCare) 于2023年11月推出的MyBreastAI套件；它结合了三款由iCAD引入的人工智慧驱动的应用程式：用于2D乳房X光检查的SecondLook、用于3D乳房X光检查的ProFound AI以及PowerLook密度评估。该套件利用人工智慧技术简化乳房成像流程，以便更快地进行诊断，从而改善此类成像的可及性。这些技术都满足了市场对更优质、更精准的癌症检测设备日益增长的需求，并将进一步促进乳房影像市场的需求。

政府和医疗机构提高乳癌认知度的倡议

日益增多的宣传活动和政府倡议使得越来越多的乳房影像服务得以应用，因为早期检测对于生存至关重要。世界各国政府和组织正在推出乳癌筛检项目，扩大影像服务的可近性，特别是针对服务匮乏的人。这些倡议反过来又将诊断技术扩展到了先前尚未普及的领域，进一步刺激了市场成长。例如，每两年，由政府资助的澳洲国家筛检计画「澳洲乳房筛检」（BreastScreen Australia）都会为50-74岁的女性提供免费的乳房X光检查，以鼓励筛检和早期检测。此外，澳洲癌症协会于2020年9月发布的《早期乳癌管理指南—建议与实务要点》强调了早期诊断的重要性，从而推动了先进乳房影像技术的发展。这些倡议，加上公众意识的不断提升，在增加对高品质影像解决方案的需求以及全球乳房影像市场扩张方面发挥重要作用。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球乳房影像市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依技术

  • 电离乳房成像
    • 主要类型
      • 乳房X光检查
      • 正子断层扫描-电脑断层扫描
      • 分子乳房影像
      • 正电子发射乳房X光检查
      • 锥形束电脑断层扫描
  • 非电离乳房成像
    • 主要类型
      • 乳腺超音波检查
      • 乳房MRI
      • 自动全乳超音波检查
      • 乳房热成像
      • 电阻抗断层扫描
      • 光学成像

第七章：市场区隔：依最终用户

  • 医院
  • 诊断影像中心
  • 门诊手术中心
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格指标

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allengers Medical Systems Limited
    • Aurora Health Care Inc. (Schoen Clinic)
    • Canon Inc.
    • Carestream Health Inc. (Onex Corporation)
    • Delphinus Medical Technologies
    • Dilon Technologies Inc.
    • Fujifilm Holdings Corporation
    • GE Healthcare
    • Hologic Inc.
    • Koninklijke Philips NV
    • Micrima Limited
    • Planmed Oy
    • Siemens Healthineers AG (Cerner Corporation)
    • Toshiba Corporation
Product Code: SR112025A2147

The global breast imaging market size was valued at USD 4.86 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.30 Billion by 2033, exhibiting a CAGR of 7.10% from 2025-2033. North America currently dominates the market, holding a breast imaging market share of over 37.5% in 2024. The breast imaging market is driven by rising breast cancer prevalence, technological advancements in imaging modalities, and government initiatives promoting early detection. Increased awareness, expanding healthcare infrastructure, and artificial intelligence (AI)-driven diagnostics further boost market growth. Favorable reimbursement policies and growing demand for accurate, non-invasive screening solutions also contribute to industry expansion.

The rising incidence of breast cancer is a major driver in the breast imaging industry, necessitating early detection and advanced diagnostic solutions. In 2022, approximately 2.3 million women globally were diagnosed with breast cancer, resulting in about 670,000 deaths. However, the projections indicate a 38% increase in cases and a 68% rise in deaths by 2050. In the U.S., diagnoses have been growing by 1% annually, with a 1.4% increase per year among women under 50. This alarming trend has intensified awareness campaigns and government initiatives promoting frequent screenings, driving the adoption of mammography, ultrasound, and MRI technologies. Technological advancements like three-dimensional (3D) mammography and AI-powered imaging enhance accuracy, reducing false positives and unnecessary biopsies. Expanding healthcare infrastructure, particularly in emerging markets, improves access to screening centers, ensuring better patient outcomes and continuous innovation in imaging technology.

The U.S. breast imaging market is driven by high breast cancer prevalence, advanced healthcare infrastructure, and strong government initiatives promoting early detection with 88.90% market share. Widespread adoption of advanced imaging technologies, such as digital breast tomosynthesis (DBT) and AI-driven diagnostics, enhances accuracy and efficiency in screenings. Favorable reimbursement policies and increased awareness campaigns by organizations like the American Cancer Society further encourage regular mammograms. Additionally, ongoing research and development (R&D) efforts by key industry players contribute to technological advancements, improving imaging precision. The presence of major market players, coupled with rising investments in healthcare innovations, strengthening the breast imaging market growth. Expanding insurance coverage and growing demand for personalized diagnostics further support the increasing adoption of breast imaging solutions across the country.

Breast Imaging Market Trends:

Increasing Incidence of Breast Cancer

On of the primary breast imaging market trends is the increasing number of breast cancer cases is one of the leading factors driving the growth of the breast imaging sector. Early detection improves survival and hence the treatment, thus surging demand for advanced imaging. It is the most commonly diagnosed cancer among women, as per WHO, necessitating accurate and timely detection of breast cancer. According to the World Cancer Research Fund, it is anticipated that there will be around 2.1 million new breast cancer cases in 2030, strengthening the argument for effective screening and imaging solutions. The rise of breast cancer cases drives the introduction of advanced imaging technologies while pushing the health system and providers to adopt better options in secure diagnosis. The measure of early detection is instrumental in improving treatment outcomes, and the demand for breast imaging services rises to accommodate these increased demand variables and the market for breast imaging.

Technological Advancements in Imaging Techniques

Continuous advancement in breast imaging technology significantly influences enhancement in detection and management of breast illnesses and conditions and is projected as a key driver for market growth. Notably, advancement in digital mammography, 3D tomosynthesis, contrast-enhanced mammography, and AI-driven imaging solutions, all contribute to increased diagnostic precision and efficiency, which in turn drives adoption. Innovations such as these allow healthcare providers to make earlier and more precise diagnoses of breast cancer, leading to improved outcomes for patients. An excellent recent example is the MyBreastAI suite launched by GE HealthCare in November 2023; it combines three iCAD-introduced AI-driven applications: SecondLook for 2D mammography, ProFound AI for 3D mammography, and PowerLook Density Assessment. This suite uses AI technology to streamline breast imaging for quicker diagnosis, thereby improving access to this kind of imaging. These technologies are all answers to the growing demand for better and more accurate devices for cancer detection that will further facilitate the breast imaging market demand.

Government and Healthcare Initiatives for Breast Cancer Awareness

The increasing awareness campaigns and government initiatives are allowing more and more breast imaging services to be utilized as early detection is very crucial to survival. Governments and organizations around the world are introducing breast cancer screening programs, expanding access to imaging services, especially for underserved populations. These, in turn, have expanded diagnostics into areas where they had previously not been available, further spurring market growth. For instance, every two years, the government-sponsored national screening program of Australia, BreastScreen Australia, offers women ages 50-74 free mammograms to encourage screening and early detection. Moreover, Cancer Australia's September 2020 publication, "Guidance for the Management of Early Breast Cancer-Recommendations and Practice Points," emphasized the significance of early diagnosis, stimulating the development of advanced breast imaging technologies. These instances, accompanied by a growing awareness among the public, are playing an important role in increasing the demand for high-quality imaging solutions and expanding the breast imaging market globally.

Breast Imaging Industry Segmentation:

Analysis by Technology:

  • Ionizing Breast Imaging
    • Mammography
    • Positron Emission Tomography-Computed Tomography
    • Molecular Breast Imaging
    • Positron Emission Mammography
    • Cone-Beam Computed Tomography
  • Non-Ionizing Breast Imaging
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-Breast Ultrasound
    • Breast Thermography
    • Electric Impedance Tomography
    • Optical Imaging

According to the breast imaging market forecast, Ionizing breast imaging holds the majority share of 63.7% due to its widespread use in early breast cancer detection and diagnosis. Techniques such as mammography, digital breast tomosynthesis (DBT), and contrast-enhanced mammography provide high-resolution images, enabling accurate identification of abnormalities. The effectiveness of these methods in detecting microcalcifications and early-stage tumors makes them the preferred choice among healthcare providers. Additionally, government screening programs, rising breast cancer awareness, and increased adoption of advanced imaging technologies contribute to its dominance. The integration of artificial intelligence in mammography for improved diagnostic accuracy and workflow efficiency further strengthens market growth. Despite concerns over radiation exposure, continuous technological advancements in low-dose imaging ensure its continued preference in breast cancer diagnostics.

Analysis by End-User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Based on the breast imaging market outlook, Hospitals hold the largest market share of 42.0% due to their comprehensive veterinary care services, advanced diagnostic capabilities, and specialized treatment options. These facilities offer a wide range of medical interventions, including surgeries, critical care, and disease management, making them the preferred choice for pet owners and livestock farmers. The presence of skilled veterinary professionals, access to high-end medical equipment, and increasing investments in hospital infrastructure contribute to their dominance. Additionally, rising pet adoption rates and growing awareness of preventive healthcare are driving demand for hospital-based veterinary services. Government initiatives and corporate investments in multi-specialty veterinary hospitals further strengthen their market position, ensuring better accessibility and higher standards of animal healthcare across urban and rural areas.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America holds the leading market position with a 37.5% breast imaging market share, fueled by a robust healthcare infrastructure, widespread adoption of advanced medical technologies, and rising healthcare expenditures. The region benefits from strong government initiatives supporting disease screening, early diagnosis, and treatment advancements. A growing prevalence of chronic diseases, coupled with a rising aging population, fuels demand for cutting-edge medical imaging and diagnostic solutions. Additionally, robust research and development activities, along with a high concentration of key industry players, contribute to market growth. Favorable reimbursement policies and widespread health insurance coverage further boost accessibility to medical imaging services. Increasing awareness programs and strong regulatory frameworks ensure continued investment in healthcare innovations, reinforcing North America's market dominance.

Key Regional Takeaways:

United States Breast Imaging Market Analysis

Growing demand for next-generation breast imaging technologies in the US stems from the large number of regulatory clearances, growing rates of breast cancer diagnoses, and revised screening guidelines. In January 2021, Seno Medical Instruments gained Premarket Approval from CDRH for its new diagnostic modality in imaging, which is centered on the malignant vs. benign differentiation of breast lesions. This approval supports the rising adoption of advanced imaging solutions for accurate diagnosis. Meanwhile, the guidance from the CDC, released in September 2020, and recommendations from major institutes for cancer research on yearly screenings for women, aged 40 to 49, run a further push for the demand for imaging services. The Breastcancer.org states that around 281,550 fresh cases of invasive in women were diagnosed in the U.S. of breast cancer, enhancing the demand for early detection technologies. A combination of these factors results in the expanding breast imaging market in the United States.

Europe Breast Imaging Market Analysis

The increase in aging populace in Europe is a key driving force behind the growth of the breast imaging market, as aging is a significant risk factor for breast cancer. As per a report by the European Union, by February 2025, over 21.3% of the total EU population which is approximately 448.8 million-was aged 65 years and older in 2023. The changing demographics are foreseen to result in an increased incidence of breast cancer, hence driving the demand for advanced breast imaging technologies. With focus across Europe on early detection and preventive care, investments in screening programs and diagnostic imaging solutions are continuing to rise. Governments and healthcare companies are expanding the access to mammography, ultrasound, and MRI-based breast imaging services to respond to the rising need for timely and accurate diagnoses. Thus, the rising population and growing healthcare initiatives were expected to drive the European breast imaging market in the coming years.

Asia Pacific Breast Imaging Market Analysis

The increasing number of breast cancer incidences recorded in the Asia Pacific region, coupled with improving healthcare infrastructure, act as the main growth driver for the breast imaging market. According to a report published by Breast Cancer Network Australia in September 2024, approximately 20,973 women and 221 men will be diagnosed with breast cancer in Australia alone. This rising number of cases highlights the requirement for advanced breast imaging technologies to enable early identification and efficient treatment.

Governments and healthcare organizations in the region are investing in newer screening technologies, including digital mammography, ultrasound, and MRI services. Supportive initiatives on breast cancer awareness and early screening programs provide good access to breast imaging services, especially in developing countries. With ongoing improvements in healthcare infrastructure and adoption of state-of-the-art imaging technologies, the demand for breast imaging solutions in the Asia Pacific region is projected to grow steadily in the future.

Latin America Breast Imaging Market Analysis

Breast cancer is the most prevalent form of cancer among women in Latin America and Caribbean countries, compelling a growing interest in the development of advanced breast imaging technologies. According to the American Society of Clinical Oncology (ASCO), more than 200,000 new cases of breast cancer were diagnosed in the region in 2020. As such increased incidence demands for greater awareness and provides an impelling reason for the development of breast imaging market.

Breast cancer screening programs are actively implemented across the Latin American region by the government and health agencies to promote the early detection of this disease. Investment in advanced imaging modalities, including digital mammography, ultrasound, and MRI, has opened the door to equitable access to high-quality diagnostics. Also, awareness campaigns and partnerships with global health institutions are slowly closing the programs that detect breast cancer among poor communities. As these health systems develop and screening access improves, demand for breast imaging solutions is expected to rise steadily across Latin America.

Middle East and Africa Breast Imaging Market Analysis

The trials of rising breast cancer incidence in the Middle East and North Africa (MENA) are among the major forces influencing breast imaging growth. In 2019, there were 835,576 breast cancer cases among females and 10,938 among males, as per the Institute for Health Metrics and Evaluation (IHME). Incidence and burden of breast cancer here drive home the point quite well about the need for deployment of advanced imaging technology and methods for early detection and improved outcomes.

Governments and healthcare institutions in the Middle East and Africa are investing in expanding access to breast cancer screening programs. Countries such as the UAE, Saudi Arabia, and South Africa are implementing nationwide initiatives promoting regular mammograms and early diagnosis. The increasing adoption of digital mammography, 3D tomosynthesis, and AI-powered imaging solutions increases accuracy and accessibility to diagnosis. Furthermore, rising healthcare awareness, improved medical infrastructure, and partnerships with international health organizations will calm beyond the horizon in the regional market.

Competitive Landscape:

The breast imaging market is highly competitive, driven by continuous technological advancements and innovation in diagnostic imaging solutions. Market players focus on research and development to enhance imaging accuracy, reduce false positives, and integrate artificial intelligence for improved diagnostics. The industry sees strong competition in product differentiation, with companies offering advanced modalities such as digital breast tomosynthesis, automated breast ultrasound, and molecular breast imaging. Strategic collaborations with healthcare providers and research institutions play a crucial role in market positioning. Regulatory approvals and compliance with stringent safety standards influence market dynamics. Additionally, increasing mergers and acquisitions help companies expand their portfolios and global reach, intensifying competition while driving the overall evolution of breast imaging technologies.

The report provides a comprehensive analysis of the competitive landscape in the breast imaging market with detailed profiles of all major companies, including:

  • Allengers Medical Systems Limited
  • Aurora Health Care Inc. (Schoen Clinic)
  • Canon Inc.
  • Carestream Health Inc. (Onex Corporation)
  • Delphinus Medical Technologies
  • Dilon Technologies Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Micrima Limited
  • Planmed Oy
  • Siemens Healthineers AG (Cerner Corporation)
  • Toshiba Corporation

Key Questions Answered in This Report

  • 1.How big is the breast imaging market?
  • 2.What is the future outlook of breast imaging market?
  • 3.What are the key factors driving the breast imaging market?
  • 4.Which region accounts for the largest breast imaging market share?
  • 5.Which are the leading companies in the global breast imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Breast Imaging Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Ionizing Breast Imaging
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Mammography
      • 6.1.2.2 Positron Emission Tomography-Computed Tomography
      • 6.1.2.3 Molecular Breast Imaging
      • 6.1.2.4 Positron Emission Mammography
      • 6.1.2.5 Cone-Beam Computed Tomography
    • 6.1.3 Market Forecast
  • 6.2 Non-Ionizing Breast Imaging
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Breast Ultrasound
      • 6.2.2.2 Breast MRI
      • 6.2.2.3 Automated Whole-Breast Ultrasound
      • 6.2.2.4 Breast Thermography
      • 6.2.2.5 Electric Impedance Tomography
      • 6.2.2.6 Optical Imaging
    • 6.2.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Imaging Centers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Indicators

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Allengers Medical Systems Limited
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Aurora Health Care Inc. (Schoen Clinic)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Canon Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Carestream Health Inc. (Onex Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 Delphinus Medical Technologies
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Dilon Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Fujifilm Holdings Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 GE Healthcare
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Hologic Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Koninklijke Philips N.V.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Micrima Limited
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Planmed Oy
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
    • 13.3.13 Siemens Healthineers AG (Cerner Corporation)
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
    • 13.3.14 Toshiba Corporation
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
      • 13.3.14.3 Financials
      • 13.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Breast Imaging Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Imaging Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Breast Imaging Market: Breakup by Technology (in %), 2024
  • Figure 4: Global: Breast Imaging Market: Breakup by End-User (in %), 2024
  • Figure 5: Global: Breast Imaging Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Breast Imaging Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Breast Imaging (Ionizing Breast Imaging) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Breast Imaging (Ionizing Breast Imaging) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Breast Imaging (Non-Ionizing Breast Imaging) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Breast Imaging (Non-Ionizing Breast Imaging) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Breast Imaging (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Breast Imaging (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Breast Imaging (Diagnostic Imaging Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Breast Imaging (Diagnostic Imaging Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Breast Imaging (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Breast Imaging (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Breast Imaging (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Breast Imaging (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: North America: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: North America: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: United States: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: United States: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Canada: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Canada: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Asia Pacific: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Asia Pacific: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: China: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: China: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Japan: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Japan: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: India: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: India: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: South Korea: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: South Korea: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Australia: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Indonesia: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Indonesia: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Others: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Others: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Germany: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Germany: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: France: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: France: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United Kingdom: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United Kingdom: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Italy: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Italy: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Spain: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Spain: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Russia: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Russia: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Latin America: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Latin America: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Brazil: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Brazil: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Mexico: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Mexico: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Middle East and Africa: Breast Imaging Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Middle East and Africa: Breast Imaging Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Global: Breast Imaging Industry: SWOT Analysis
  • Figure 68: Global: Breast Imaging Industry: Value Chain Analysis
  • Figure 69: Global: Breast Imaging Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Imaging Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Breast Imaging Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Breast Imaging Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 4: Global: Breast Imaging Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Breast Imaging Market: Competitive Structure
  • Table 6: Global: Breast Imaging Market: Key Players